Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12594304 | Method for treating liver cirrhosis by using composition comprising mesenchymal stem cell. extracellular vesicle produced by mesenchymal stem cell, and growth factor | 🖼🧊📄§ | 2026-04-07 | 2043-10-04 | 0 | 31 |
| 12594310 | Composition comprising lactic acid bacteria derived from green tea for improving liver function | 🖼🧊📄§ | 2026-04-07 | 2043-05-08 | 0 | 31 |
| 12594312 | Bacteriophage compositions for treating Pseudomonas infection | 🖼🧊📄§ | 2026-04-07 | 2041-04-27 | 0 | 31 |
| 12594311 | Lactobacillus plantarum PDG8 and use in treating cardiovascular diseases | 🖼🧊📄§ | 2026-04-07 | 2043-05-24 | 0 | 31 |
| 12594315 | Use of Liriodendron chinense (Hemsl.) Sarg. or extract thereof in the preparation of medicament for reducing serum uric acid level and preventing and treating uric acid nephropathy | 🖼🧊📄§ | 2026-04-07 | 2040-10-23 | 0 | 31 |
| 12594321 | Bispecific chimeric antigen receptor that binds CD19 and CD20, encoding nucleic acid molecules thereof and methods of use thereof to treat cancer | 🖼🧊📄§ | 2026-04-07 | 2043-12-05 | 0 | 31 |
| 12594319 | Pharmaceutical development | 🖼🧊📄§ | 2026-04-07 | 2040-07-28 | 0 | 31 |
| 12594325 | Interleukin-18 variants and methods of use | 🖼🧊📄§ | 2026-04-07 | 2044-11-08 | 0 | 31 |
| 12594323 | Methods of reducing neuroinflammation | 🖼🧊📄§ | 2026-04-07 | 2043-04-13 | 0 | 31 |
| 12594338 | Cisplatin analogue with potent anti-cancer effects and synthesis thereof | 🖼🧊📄§ | 2026-04-07 | 2043-07-27 | 0 | 31 |
| 12594334 | ETAR antibody, and pharmaceutical compositions and use thereof | 🖼🧊📄§ | 2026-04-07 | 2043-01-17 | 0 | 31 |
| 12594341 | Multifunctional immunotherapeutic monoclonal antibody complexes and conjugates | 🖼🧊📄§ | 2026-04-07 | 2041-06-14 | 0 | 31 |
| 12594343 | Treatment of cancer | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12594344 | Production of exosomes and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2042-12-02 | 0 | 31 |
| 12594348 | Compositions for treating Friedreich's ataxia | 🖼🧊📄§ | 2026-04-07 | 2040-12-18 | 0 | 31 |
| 12589078 | Lipid nanoparticles for delivery of nucleic acids | 🖼🧊📄§ | 2026-03-31 | 2040-12-18 | 0 | 31 |
| 12589147 | Multivalent HVT vector vaccine | 🖼🧊📄§ | 2026-03-31 | 2040-12-18 | 0 | 31 |
| 12589070 | Low-dosage orodispersible opioid tablet and method for preparing same | 🖼🧊📄§ | 2026-03-31 | 2040-08-13 | 0 | 31 |
| 12589136 | Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies | 🖼🧊📄§ | 2026-03-31 | 2042-08-09 | 0 | 31 |
| 12590292 | Targeted T-cell therapy for treatment of multiple myeloma | 🖼🧊📄§ | 2026-03-31 | 2040-01-07 | 0 | 31 |
| 12590304 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | 🖼🧊📄§ | 2026-03-31 | 2040-05-21 | 0 | 31 |
| 12590335 | Targeted measure of transcriptional activity related to hormone receptors | 🖼🧊📄§ | 2026-03-31 | 2043-06-21 | 0 | 31 |
| 12590309 | Reprogramming of lipid metabolism to inhibit T cell senescence and enhance tumor immunotherapy | 🖼🧊📄§ | 2026-03-31 | 2040-05-19 | 0 | 31 |
| 12589125 | Yogurt for regulating intestinal tract, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-03-31 | 2043-02-27 | 0 | 31 |
| 12590168 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2044-01-23 | 0 | 31 |
| 12590123 | Compounds and methods for treating cancer, viral infections, and allergic conditions | 🖼🧊📄§ | 2026-03-31 | 2040-06-25 | 0 | 31 |
| 12590139 | MHC class II molecules and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-29 | 0 | 31 |
| 12590103 | Polymorph of EP4 receptor antagonist, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-01-29 | 0 | 31 |
| 12590157 | Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments | 🖼🧊📄§ | 2026-03-31 | 2043-07-20 | 0 | 31 |
| 12589133 | Methods of downregulating CCL20 genes for treatment of traumatic brain injuries | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12590100 | Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease | 🖼🧊📄§ | 2026-03-31 | 2042-01-13 | 0 | 31 |
| 12590149 | Antibody and bispecific antibody targeting LAG-3 and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-06-11 | 0 | 31 |
| 12589122 | Methods and compositions for treating infectious, autoimmune, and allergic disease | 🖼🧊📄§ | 2026-03-31 | 2039-11-05 | 0 | 31 |
| 12589092 | Polycyclic compound acting as kinase inhibitor | 🖼🧊📄§ | 2026-03-31 | 2041-01-11 | 0 | 31 |
| 12589121 | Method for obtaining occlusive biological dressing, occlusive biological dressing, use thereof and kit | 🖼🧊📄§ | 2026-03-31 | 2039-11-14 | 0 | 31 |
| 12589115 | Haematopoietic stem cell treatment | 🖼🧊📄§ | 2026-03-31 | 2039-03-29 | 0 | 31 |
| 12589085 | Use of diaminoguanidine derivative and feed composition thereof in preparation of veterinary drug | 🖼🧊📄§ | 2026-03-31 | 2039-07-22 | 0 | 31 |
| 12589094 | Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4 | 🖼🧊📄§ | 2026-03-31 | 2044-02-28 | 0 | 31 |
| 12589113 | Preparation of a therapeutic composition for treating autoimmune diseases | 🖼🧊📄§ | 2026-03-31 | 2044-10-01 | 0 | 31 |
| 12589081 | Curcumin compositions for osteoarthritis and joint wellness | 🖼🧊📄§ | 2026-03-31 | 2040-12-02 | 0 | 31 |
| 12589101 | Cyclodextrin protein drug conjugates | 🖼🧊📄§ | 2026-03-31 | 2042-06-10 | 0 | 31 |
| 12589164 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2045-03-14 | 0 | 31 |
| 12589158 | GLP-1/GIP dual agonist, preparation method and use thereof | 🖼🧊📄§ | 2026-03-31 | 2044-03-12 | 0 | 31 |
| 12589096 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | 🖼🧊📄§ | 2026-03-31 | 2045-07-21 | 0 | 31 |
| 12590307 | Translation enhancing nucleic acid compounds: ASO coupled translation-upregulation 1 (ACT-UP1) and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2045-02-14 | 0 | 31 |
| 12589152 | Composition for enhanced absorption of supplements | 🖼🧊📄§ | 2026-03-31 | 2042-12-16 | 0 | 31 |
| 12590054 | Use of D9-methadone for postoperative pain relief | 🖼🧊📄§ | 2026-03-31 | 2042-12-22 | 0 | 31 |
| 12590320 | Cellular models of and therapies for ocular diseases | 🖼🧊📄§ | 2026-03-31 | 2038-07-31 | 0 | 31 |
| 12589088 | Compositions and methods for treating cancer with andrographolide and melatonin combination therapy | 🖼🧊📄§ | 2026-03-31 | 2041-04-30 | 0 | 31 |
| 12589124 | Bifidobacterium longum | 🖼🧊📄§ | 2026-03-31 | 2041-03-12 | 0 | 31 |